background

Dihydroergotamine EP Impurity E

Dihydroergotamine EP Impurity E Watermark

Dihydroergotamine EP Impurity E

CAT No:CL-DHET-06
CAS No:17479-19-5
Mol.F:C35H41N5O5
Mol.Wt.:611.7
Chemical Name:(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-(1-methylethyl)-3,6-dioxo-octahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
Inventory Status:Custom synthesis

This impurity is related to Dihydroergotamine EP Impurity E is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Dihydroergotamine EP Impurity E is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-(1-methylethyl)-3,6-dioxo-octahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Dihydroergotamine
Molecular Formula: C35H41N5O5
Molecular Weight: 611.7
Storage: Store in a cool, dry place.

Document